ICON Operating Income 2010-2024 | ICLR
ICON annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- ICON operating income for the quarter ending September 30, 2024 was $0.285B, a 7.99% increase year-over-year.
- ICON operating income for the twelve months ending September 30, 2024 was $1.066B, a 19.29% increase year-over-year.
- ICON annual operating income for 2023 was $0.956B, a 20.23% increase from 2022.
- ICON annual operating income for 2022 was $0.795B, a 110.09% increase from 2021.
- ICON annual operating income for 2021 was $0.379B, a 3.31% decline from 2020.
| ICON Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $956 |
| 2022 | $795 |
| 2021 | $379 |
| 2020 | $392 |
| 2019 | $433 |
| 2018 | $373 |
| 2017 | $338 |
| 2016 | $312 |
| 2015 | $282 |
| 2014 | $202 |
| 2013 | $121 |
| 2012 | $68 |
| 2011 | $39 |
| 2010 | $92 |
| 2009 | $116 |
| ICON Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-09-30 | $285 |
| 2024-06-30 | $230 |
| 2024-03-31 | $285 |
| 2023-12-31 | $266 |
| 2023-09-30 | $264 |
| 2023-06-30 | $209 |
| 2023-03-31 | $217 |
| 2022-12-31 | $203 |
| 2022-09-30 | $244 |
| 2022-06-30 | $178 |
| 2022-03-31 | $170 |
| 2021-12-31 | $145 |
| 2021-09-30 | $5 |
| 2021-06-30 | $113 |
| 2021-03-31 | $116 |
| 2020-12-31 | $120 |
| 2020-09-30 | $108 |
| 2020-06-30 | $57 |
| 2020-03-31 | $106 |
| 2019-12-31 | $115 |
| 2019-09-30 | $110 |
| 2019-06-30 | $106 |
| 2019-03-31 | $102 |
| 2018-12-31 | $102 |
| 2018-09-30 | $98 |
| 2018-06-30 | $82 |
| 2018-03-31 | $92 |
| 2017-12-31 | $90 |
| 2017-09-30 | $85 |
| 2017-06-30 | $78 |
| 2017-03-31 | $86 |
| 2016-12-31 | $85 |
| 2016-09-30 | $77 |
| 2016-06-30 | $74 |
| 2016-03-31 | $76 |
| 2015-12-31 | $75 |
| 2015-09-30 | $71 |
| 2015-06-30 | $68 |
| 2015-03-31 | $67 |
| 2014-12-31 | $52 |
| 2014-09-30 | $59 |
| 2014-06-30 | $48 |
| 2014-03-31 | $43 |
| 2013-12-31 | $30 |
| 2013-09-30 | $33 |
| 2013-06-30 | $31 |
| 2013-03-31 | $130 |
| 2012-12-31 | $19 |
| 2012-09-30 | $21 |
| 2012-06-30 | $17 |
| 2012-03-31 | $102 |
| 2011-12-31 | $7 |
| 2011-09-30 | $1 |
| 2011-06-30 | $16 |
| 2011-03-31 | $92 |
| 2010-12-31 | $112 |
| 2010-09-30 | $18 |
| 2010-06-30 | $26 |
| 2010-03-31 | $27 |
| 2009-12-31 | $30 |
| 2009-09-30 | $30 |
| 2009-06-30 | $29 |
| 2009-03-31 | $27 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $16.343B | $8.120B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $89.358B | 11.09 |
| Cencora (COR) | United States | $46.783B | 17.59 |
| DiDi Global (DIDIY) | China | $22.844B | 0.00 |
| Natera (NTRA) | United States | $20.907B | 0.00 |
| Avantor (AVTR) | United States | $15.048B | 22.56 |
| Revvity (RVTY) | United States | $14.408B | 25.03 |
| BioMerieux (BMXMF) | France | $13.788B | 0.00 |
| Viatris (VTRS) | United States | $13.488B | 4.15 |
| Solventum (SOLV) | United States | $12.699B | 0.00 |
| CochLear (CHEOY) | Australia | $12.341B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.485B | 29.54 |
| Doximity (DOCS) | United States | $10.029B | 59.03 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.551B | 0.00 |
| HealthEquity (HQY) | United States | $8.876B | 44.53 |
| Charles River Laboratories (CRL) | United States | $8.361B | 16.16 |
| Sonic Healthcare (SKHHY) | Australia | $8.244B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
| Bausch + Lomb (BLCO) | Canada | $6.118B | 28.46 |
| Organon (OGN) | United States | $4.054B | 4.09 |
| Sotera Health (SHC) | United States | $3.676B | 19.67 |
| BrightSpring Health Services (BTSG) | United States | $3.230B | 68.70 |
| Alignment Healthcare (ALHC) | United States | $2.795B | 0.00 |
| Concentras Parent (CON) | United States | $2.691B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.566B | 29.26 |
| Premier (PINC) | United States | $2.156B | 11.22 |
| PACS (PACS) | United States | $2.106B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.013B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.909B | 0.00 |
| Progyny (PGNY) | United States | $1.788B | 36.21 |
| GoodRx Holdings (GDRX) | United States | $1.742B | 45.70 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.658B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.565B | 0.00 |
| Agilon Health (AGL) | United States | $1.273B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.189B | 11.63 |
| CareDx (CDNA) | United States | $1.150B | 0.00 |
| Embecta (EMBC) | United States | $1.086B | 7.59 |
| AMN Healthcare Services Inc (AMN) | United States | $0.986B | 6.67 |
| Establishment Labs Holdings (ESTA) | $0.968B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.624B | 0.00 |
| SBC Medicals (SBC) | United States | $0.518B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.484B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.429B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.426B | 11.15 |
| DocGo (DCGO) | United States | $0.426B | 16.04 |
| Enhabit (EHAB) | United States | $0.402B | 34.74 |
| MultiPlan (MPLN) | United States | $0.260B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.239B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.217B | 0.00 |
| Beauty Health (SKIN) | United States | $0.216B | 0.00 |
| LifeMD (LFMD) | United States | $0.212B | 0.00 |
| Nutex Health (NUTX) | United States | $0.206B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.181B | 0.00 |
| Biodesix (BDSX) | United States | $0.167B | 0.00 |
| So-Young (SY) | China | $0.110B | 18.60 |
| ModivCare (MODV) | United States | $0.093B | 5.03 |
| Ascend Wellness Holdings (AAWH) | United States | $0.085B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 1.63 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| Oncology Institute (TOI) | United States | $0.042B | 0.00 |
| OncoCyte (OCX) | United States | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.032B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.025B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.025B | 0.00 |
| KindlyMD (KDLY) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |